Vasopresina: usos en la práctica cardiovascular

Chon, Octavio González; García López, Sandra María del Carmen.
Arch. cardiol. Méx ; 72(3): 249-260, jul.-set. 2002.
Artículo en Español | LILACS | ID: lil-329823

Documentos relacionados

  1. The Vasopressin Loading for Refractory septic shock (VALOR) study: a prospective observational study.
  2. Real life use of vasopressin in patients with cardiogenic shock: a retrospective cohort analysis.
  3. Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock.
  4. The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis.
  5. Vasopressin in newborns with refractory acute pulmonary hypertension.
  6. Augmented-Medication CardioPulmonary Resuscitation Trials in out-of-hospital cardiac arrest: a pilot randomized controlled trial.
  7. Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock.
  8. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
  9. A critical reappraisal of vasopressin and steroids in in-hospital cardiac arrest.
  10. Potential Confounders in Study Concluding Higher Lactate at Vasopressin Initiation Is Associated With Higher Mortality in Septic Shock.